Drug companies lose money when manufacturing drugs that cure those suffering from rare diseases because selling a drug to only a few people usually does not recoup manufacturing expenses.Therefore, a company manufacturing any of the drugs that cure those suffering from loxemia, an extremely rare disease, will undoubtedly lose money.